Literature DB >> 15638794

Involvement of cannabinoids in cellular proliferation.

María L López-Rodríguez1, Alma Viso, Silvia Ortega-Gutiérrez, Inés Díaz-Laviada.   

Abstract

The endogenous canabinoid system (ECS) is involved in the regulation of an important number of central and peripheral physiological effects. Among all these functions, the control of the cellular proliferation has become a focus of major attention as opening new therapeutic possibilities for the use of cannabinoids as potential antitumor agents. The capacity of endogenous and synthetic cannabinoids to induce apoptosis of different tumoral cells in culture and in vivo, the mechanism underlying and the potential therapeutic applications are discussed in this review.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15638794     DOI: 10.2174/1389557053402819

Source DB:  PubMed          Journal:  Mini Rev Med Chem        ISSN: 1389-5575            Impact factor:   3.862


  5 in total

1.  CB2 cannabinoid receptor agonists attenuate TNF-alpha-induced human vascular smooth muscle cell proliferation and migration.

Authors:  M Rajesh; P Mukhopadhyay; G Haskó; J W Huffman; K Mackie; P Pacher
Journal:  Br J Pharmacol       Date:  2007-11-12       Impact factor: 8.739

2.  A novel near-infrared fluorescence imaging probe that preferentially binds to cannabinoid receptors CB2R over CB1R.

Authors:  Xiaoxi Ling; Shaojuan Zhang; Pin Shao; Weixia Li; Ling Yang; Ying Ding; Cong Xu; Nephi Stella; Mingfeng Bai
Journal:  Biomaterials       Date:  2015-04-28       Impact factor: 12.479

3.  Receptor-targeted nanoparticles modulate cannabinoid anticancer activity through delayed cell internalization.

Authors:  Matilde Durán-Lobato; Josefa Álvarez-Fuentes; Mercedes Fernández-Arévalo; Lucía Martín-Banderas
Journal:  Sci Rep       Date:  2022-01-25       Impact factor: 4.379

4.  Inhibition of human tumour prostate PC-3 cell growth by cannabinoids R(+)-Methanandamide and JWH-015: involvement of CB2.

Authors:  N Olea-Herrero; D Vara; S Malagarie-Cazenave; I Díaz-Laviada
Journal:  Br J Cancer       Date:  2009-08-18       Impact factor: 7.640

5.  Substrate-selective COX-2 inhibition decreases anxiety via endocannabinoid activation.

Authors:  Daniel J Hermanson; Nolan D Hartley; Joyonna Gamble-George; Naoko Brown; Brian C Shonesy; Phillip J Kingsley; Roger J Colbran; Jeffrey Reese; Lawrence J Marnett; Sachin Patel
Journal:  Nat Neurosci       Date:  2013-08-04       Impact factor: 24.884

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.